Published on September 21, 2017
There are four drugs approved for prostate cancer patients with metastatic disease. Dr. Bertrand Tombal, Chairman of Urology at Cliniques Universitaires Saint Luc, explains the available drugs and how they can benefit patients.
This interview was recorded at the European Society of Medical Oncology (ESMO) congress held in Madrid (Spain, September 2017). Prostate cancer videos recorded at ESMO 17 are part of an educational program by the Patient Empowerment Foundation (PEF). We thank Bayer for their support.